Get SEC filing alerts via email and in your feed for INSMED Inc
INSM
INSMED Inc
About INSMED Inc
Insmed Incorporated is a biopharmaceutical company focused on developing and commercializing therapies for serious diseases, including rare lung infections and inflammatory conditions. Its flagship product, ARIKAYCE, treats nontuberculous mycobacterial lung disease using liposomal inhalation technology. The company also advances pipeline candidates in gene therapy, pulmonary hypertension, and inflammatory diseases, leveraging proprietary platforms, strategic licensing, and a global manufacturing and patent portfolio.
This description was generated via AI from an annual report.
Updated 8 months ago.